PT Tempo Scan Pacific operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares PT Tempo Scan Pacific with three other
pharmaceutical manufacturers in Asia:
Piramal Enterprises Limited
sales of 34.96 billion Indian Rupees [US$581.72 million]
of which 71%
Northeast Pharmaceutical Group Co., Ltd.
(3.87 billion Chinese Renmimbi [US$623.14 million]
of which 90%
was Pharmaceutical Products), and
Kunming Pharmaceutical Group Ltd.
based in China
(3.58 billion Chinese Renmimbi [US$577.69 million]
of which 53%
was Pharmaceutical Manufacturing).
PT Tempo Scan Pacific reported sales of 6.85 trillion Indonesian Rupiahs (US$590.89 million)
December of 2013.
increase of 3.4%
versus 2012, when the company's sales were 6.63 trillion Indonesian Rupiahs.
Sales at PT Tempo Scan Pacific have increased during each of the previous five years
(and since 2008, sales have increased a total of 89%).
Sales of Consumer Products and Cosmetics saw an increase
that was more than double the company's growth rate: sales were up
9.7% in 2013, from
1.53 trillion Indonesian Rupiahs to 1.67 trillion Indonesian Rupiahs.
Not all segments of PT Tempo Scan Pacific experienced an increase in sales in 2013:
sales of Distribution Services fell 0.1% to 3.19 trillion Indonesian Rupiahs.